A review of mortality in type 2 diabetes mellitus
https://doi.org/10.14341/DM6846
Abstract
The morbidity and mortality associated with type 2 diabetes have increased over recent years. The causes of death include cardiovascular disease, cancer, infection, kidney disease and diabetic coma. Risk factors for death are a sedentary lifestyle, obesity, smoking, sex, age, duration and severity of diabetes, macro- and microvascular complications and hyper- and hypoglycaemic states. Adequate glycemic control and moderate exercise along with the use of antiplatelet agents (e.g. aspirin), statins, antihypertensives and metformin can reduce mortality. Intensive glucose control was associated with an increased risk of severe hypoglycaemia and death, and surgical intervention increased the risk of death.
About the Author
Nailya Sayfullaevna Asfandiyarova
Ryazan State Medical University
Russian Federation
MD, PhD, Assistance professor
Competing Interests: Конфликта интересов нет
Russian Federation
MD, PhD, Assistance professor
Competing Interests: Конфликта интересов нет
References
1. IDF Diabetes Atlas. 5-th edition. 2012. Available from: http://www.idf.org/diabetesatlas/5e/
2. Botnariu G, Bulgaru-Iliescu D. Determinant factors of cardiovascular mortality in type 2 diabetic patients: literature review. Rom J Leg Med. 2010;18(4):309-314. doi: 10.4323/rjlm.2010.309
3. Мировая статистика здравоохранения 2012. Доклад ВОЗ. 2013, 1-180. Доступно по ссылке:http://apps.who.int/iris/bitstream/10665/44844/8/9789244564448_rus.pdf [World health statistics 2012. The report. 2013:1-180. Available from: http://apps.who.int/iris/bitstream/10665/44844/8/9789244564448_rus.pdf (In Russ.)]
4. Palumbo PJ, Elveback LR, Chu CP, et al. Diabetes mellitus: incidence, prevalence, survivorship, and causes of death in Rochester, Minnesota, 1945-1970. Diabetes. 1976;25(7):566-573. doi: 10.2337/diab.25.7.566
5. Gu K, Cowie CC, Harris MI. Mortality in adults with and without diabetes in National Cohort of the U.S. population, 1971-1973. Diabetes Care. 1998;21(7):1138-1145. doi: 10.2337/diacare.21.7.1138
6. Roglic G, Unwin N, Benneth PH, et al. The burden of mortality attributable to diabetes: realistic estimates for the year 2000. Diabetes Care. 2005;28(9):2130-2135. doi: 10.2337/diacare.28.9.2130
7. Шестакова М.В. Комментарии эндокринолога к рекомендациям по сахарному диабету, предиабету и сердечно-сосудистым заболеваниям ESC-EASD 2007. // Сахарный диабет. – 2008. – Т. 11. - №1 – С.97-99. [Shestakova MV. Kommentarii endokrinologa k Rekomendatsiyam po sakharnomu diabetu, prediabetu i serdechno-sosudistym zabolevaniyam ESC-EASD 2007. Diabetes mellitus. 2008;11(1):97-99. (In Russ.)] doi: 10.14341/2072-0351-5955
8. Public Health Agency of Canada. Report from the National Diabetes Surveillance System: Diabetes in Canada, 2009 (Ottawa: PHAC, 2009), 6 (accessed November 16, 2011). Available from: http://www.idf.org/diabetesatlas/5e/.
9. Бичан И.В., Брызгалина С.М. Работа Государственного Регистра Сахарного Диабета в г. Новокузнецке: эпидемиологическая ситуация, качество медицинской помощи больным сахарным диабетом. // Медицина в Кузбассе. 2005. - №7 – С.13-14. [Bichan I., Bryzgalina SM. The work of the State Register of Diabetes in Novokuznetsk: epidemiological situation, the quality of medical care for diabetic patients. Medicine in Kuzbass. 2005;(7):13-14. (In Russ.)]
10. Казачкова Н.В., Кисляков В.А. Динамика причин смертности от сахарного диабета. // Успехи современного естествознания. - 2008. – №5. – С.39-41. [Kazachkova NV, Kislyakov VA. Dynamics of mortality from diabetes. Advances in current natural science. 2008;(5):39-41. (In Russ.)]
11. WHO: Diabetes mortality: age-standardized death rate per 100 000 population 2000-2012. Both sexes, 2012. Available from: http://gamapserver.who.int/gho/interactive_charts/ncd/mortality/diabetes/atlas.html
12. Mulnier HE, Seaman HE, Raleigh VS, et al. Mortality in people with type 2 diabetes in the UK. Diabet Med. 2006;23(5):516-521. doi: 10.1111/j.1464-5491.2006.01838.x
13. Hansen LJ, de Fine-Olivarius N, Siersma V. 16-year excess all-cause mortality of newly diagnosed type 2 diabetic patients: a cohort study. BMC Public Health. 2009;9:400. doi: 10.1186/1471-2458-9-400
14. Кудрякова С.В., Сунцов Ю.И. Некоторые данные регистра сахарного диабета. // Проблемы эндокринологии. – 1994 – Т. 40. - №1 – С. 4-6. [Kudryakova SV, Suntsov YuI. Some data from the diabetes register. Problems of endocrinology.1994;40(1):4-6. (In Russ.)]
15. Дедов И.И., Сунцов Ю.И., Кудрякова С.В., и др. О регистре сахарного диабета. // Проблемы эндокринологии. – 1995. – Т. 41. - №3 – С.4-7. [Dedov II, Suntsov YuI, Kudryakova ST, et al. About the diabetes register. Problems of endocrinology. 1995;41(3):4-7. (In Russ.)]
16. Сунцов Ю.И., Дедов И.И., Кудрякова С.В. Государственный регистр сахарного диабета: эпидемиологическая характеристика инсулиннезависимого сахарного диабета. // Сахарный диабет. – 1998. – Т. 1. – №1 – С. 41-43. [Suntsov YI, Dedov II, Kudryakova SV. Gosudarstvennyy registr sakharnogo diabeta: epidemiologicheskaya kharakteristika insulinnezavisimogo sakharnogo diabeta. Diabetes mellitus. 1998;1(1):41-43. (In Russ.)] doi: 10.14341/2072-0351-6215
17. Reunanen A. Mortality in type 2 diabetes. Ann Clin Res. 1983;15 Suppl 37:26-28.
18. Geiss LS, Herman WH, Smith PJ. Mortality in non-insulin-dependent diabetes. In: Harris MI. Cowie CC, Stern MP, et al, eds. Diabetes in America, 2nd ed. Washington, DC: National Diabetes Data Group, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 1995. P. 233-57.
19. Балаболкин МИ. Фармакоэкономика сахарного диабета. 1999. Доступ по ссылке: http://www.voed.ru/farmec_sd.htm. [Balabolkin MI. Farmakoekonomika sakharnogo diabeta. 1999. Available on URL: http://www.voed.ru/farmec_sd.htm (In Russ.)]
20. Sasaki A. Mortality and causes of death in patients with diabetes mellitus in Japan. Diab Res Clin Pract. 1994;24 Suppl:S299-S306. doi: 10.1016/0168-8227(94)90266-6
21. Xia Wu C, Shin Tan W, Han Sim Toh MP, et al. Derivation and validation of a risk index to predict all-cause mortality in type 2 diabetes mellitus. J Endocrinol Metabol. 2012;2(2):88-95.
22. Vasan SK, Pittard AEI, Abraham J, et al. Cause-specific mortality in diabetes: retrospective hospital based data from South India. J Diab. 2012;4(1):47-54. doi: 10.1111/j.1753-0407.2011.00165.x
23. Дедов И.И., Шестакова М.В. Сахарный диабет. - М.: «Универсум Паблишинг»; 2003. [Dedov II, Shestakova MV. Diabetes Mellitus. Moscow: «Universum Publishing»; 2003. (In Russ.)]
24. Damsgaard EM, Frøland, Mogensen CE. Over-mortality as related to age and gender in patients with established non-insulin-dependent diabetes mellitus. J Diab Compl. 1997;11(2):77-82. doi: 10.1016/S1056-8727(97)00095-0
25. Williams ED, Rawal L, Oldenburg BF, et al. Risk of cardiovascular and all-cause mortality: impact of impaired health-related functioning and diabetes. The Australian Diabetes, Obesity, and Lifestyle (AusDiab) study. Diabetes Care. 2012;35(5):1067-1073. doi: 10.2337/dc11-1288
26. De Graw WJ, van de Lisdonk EH, van den Hoogen HJ, et al. Cardiovascular morbidity and mortality in type 2 diabetic patients: a 22-year historical cohort study in Dutch general practice. Diabet Med. 1995;12(2):117-122. doi: 10.1111/j.1464-5491.1995.tb00441.x
27. Abduelkarem AR, El-Shareif HJ, Sharif SI. Prognostic indices for hospital mortality among Libyan diabetic patients. Pract Diab Int. 2010;27(9):392-395. doi: 10.1002/pdi.1528
28. Królewski AS, Szyzyk A, Janeczko D, et al. Mortality from cardiovascular disease among diabetics. Diabetologia. 1977;13(4):345-350. doi: 10.1007/BF01223277
29. Hu FB, Stampfer MJ, Solomon CG, et al. The impact of diabetes mellitus on mortality from all causes and coronary heart disease in woman. 20 years of follow-up. Arch Int Med. 2001;161(14):1717-1723. doi: 10.1001/archinte.161.14.1717
30. Mata-Cases M, De Prado-Lacueva C, Salido-Valencia V, et al. Incidence of complication and mortality in a type 2 diabetes patient cohort study followed up from diagnosis in a primary healthcare center. Int J Clin Pract. 2011;65(3):299-307. doi: 10.1111/j.1742-1241.2010.02503.x
31. De Marco R, Locatelli F, Zoppini G, et al. Cause-specific mortality in type 2 diabetes. The Verona Diabetes Study. Diabetes Care. 1999;22(5):756-761. doi: 10.2337/diacare.22.5.756
32. Zargar AH, Wani AI, Masoodi SR, et al. Causes of mortality in diabetes mellitus: data from a tertiary teaching hospital in India. Postgrad Med J. 2009;85(1003):227-232. doi: 10.1136/pgmj.2008.067975
33. Goodkin G. Mortality factors in diabetes. A 20 year mortality study. J Occup Med. 1975;17(11):716-721.
34. Hogea CM, Serban V, Rosu M, et al. Predictive mortality risk factors in diabetes mellitus (review). TMJ. 2012;62(1-2):30-33.
35. de Fine Olivarius N, Siersma V, Nielsen AB, et al. Predictors of mortality of patients newly diagnosed with clinical type 2 diabetes: a 5-year follow up study. BMC Endocr Disord. 2010;10:14. doi: 10.1186/1472-6823-10-14
36. Barkoudah E, Scali H, Uno H, et al. Mortality rates in trials of subjects with type 2 diabetes. J Am Heart Assoc. 2012;1(1):8-15. doi: 10.1161/JAHA.111.000059
37. Jarretti RJ, McCartney P, Keen H. The Bedford survey6 ten year mortality rates in newly diagnosed diabetics, borderline diabetics and normoglycaemic controls and risk induces for coronary heart disease in borderline diabetics. Diabetologia. 1982;22(2):79-84.
38. Carnethon MR, de Chavez PJ, Biggs ML, et al. Association of weight status with mortality in adults with incident diabetes. JAMA. 2012;308(6):581-590. doi: 10.1001/jama.2012.9282
39. Kokkinos P, Myers J, Faselis Ch, et al. BMI-mortality paradox and fitness in African American and Caucasian Men with type 2 diabetes. Diabetes Care. 2012;35(5)1021-1027. doi: 10.2337/dc11-2407
40. Logue J, Walker JJ, Leese G, et al. Association between BMI measured within a year after diagnosis of type 2 diabetes and mortality. Diabetes Care. 2013;36(4):887-893. doi: 10.2337/dc12-0944
41. Tobias DK, Pan A, Jackson CL, et al. Body-mass inde[ and mortality among adults with incident type 2 diabetes. N Engl J Med. 2014;370(3):233-244. doi: 10.1056/NEJMoa1304501
42. Haffner SM, Lehto S, Rönnemaa T, et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339(4):229-234. doi: 10.1056/NEJM199807233390404
43. Donahoe SM, Stewart GS, McCabe CH, et al. Diabetes and mortality following acute coronary syndrome. JAMA. 2007;298(7):765-775. doi: 10.1001/jama.298.7.765
44. Andersson DKG, Svärdsudd K. Long-term glycemic control relates to mortality in type II diabetes. Diabetes Care. 1995;18(12):1534-1543. doi: 10.2337/diacare.18.12.1534
45. Williams PT. Reduced total and cause-specific mortality from walking and running in diabetes. Med Sci Sports Exercise. 2014;46(5):933-939. doi: 10.1249/MSS.0000000000000197
46. Vepsäläinen T. Factors predicting mortality in type 2 diabetes. Turku: «Turun Yiopisto University of Turku»; 2013.
47. Croxson SC, Price DE, Burden M, et al. The mortality of elderly people with diabetes. Diab Med. 1994;11(3):250-252. doi: 10.1111/j.1464-5491.1994.tb00267.x
48. Barnett KN, McMurdo MET, Ogston SA, et al. Mortality in people diagnosed with type 2 diabetes at on older age: a systematic review. Age Ageing. 2006;35(5):463-468. doi: 10.1093/ageing/afl019
49. Young BA, Lin E, Von Korf M, et al. Diabetes complication severity index and risk of mortality, hospitalization and healthcare utilization. Am J Manag Care. 2012;18(4):213-219.
50. Lin CC, Chen CC, Kung PT, et al. Joint relation between renal function and proteinuria on mortality of patients with type 2 diabetes: The Taichung diabetes study. Cardiovasc Diabetol. 2012;11:131. doi: 10.1186/1475-2840-11-131.
51. Gamble JM, Simpson SH, Eurich DT, et al. Insulin use and increased risk of mortality in type 2 diabetes; a cohort study. Diabetes Obes Metab. 2010;12(1):47-53. doi: 10.1111/j.1463-1326.2009.01125.x
52. Currie CJ, Poole CD, Evans M, et al. Mortality and other important diabetes-related outcomes with insulin vs other antihyperglycemic therapies in type 2 diabetes. J Clin Endocrinol Metabol. 2013;98(2):668-677. doi: 10.1210/jc.2012-3042
53. Chiou WK, Hwang JSh, Hsu KH, et al. Diabetes mellitus increased mortality rates more in gender specific cancer patients: a retrospective study of 149 491 patients. Exp Diabetes Res. 2012;2012:701643. doi: 10.1155/2012/701643
54. Ranc K, Jørgensen E, Friis S, Carstensen B. Mortality after cancer among patients with diabetes mellitus: effect of diabetes duration and treatment. Diabetologia. 2014;57(5):927-934. doi: 10.1007/s00125-014-3186-z
55. Смирнова О.М., Иванникова Е.В. Терапия сахарного диабета и риск канцерогенеза. // Проблемы эндокринологии. – 2012. – Т. 58. - №2 – С.52-57. [Smirnova OM, Ivannikova EV. Therapy of diabetes mellitus and the risk of malignization. Problemy Endokrinologii. 2012;58(2):52-57. (In Russ.)] doi: 10.14341/probl201258252-57
56. Currie CJ, Poole CD, Jenkins-Jones S, et al. Mortality after incident cancer in people with and without type 2 diabetes. Diab Care. 2012;35(2):299-304. doi: 10.2337/dc11-1313
57. Landman GW, Van Hateren KJ, Kleefstra N, et al. The relationship between obesity and cancer mortality in type 2 diabetes: a ten year follow-up study (ZODIAC-21). Anticancer Res. 2010;30(2):681-682.
58. Bonds DE, Miller ME, Bergenstal RM, et al. The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study. BMJ. 2010;340:b4909. doi: 10.1136/bmj.b4909
59. Boussageon R, Bejan-Angoulvant T, Saadatian-Elahi M, et al. Effect of intensive glucose lowering treatment on all-cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomized controlled trials. BMJ. 2011;343:d4169. doi: 10.1136/bmj.d4169
60. Gaede PG, Lund-Andersen H, Parving HH, et al. Effect of multifactorial intervention on mortality in type 2 diabetes. New Engl J Med. 2008;358:580-591. doi: 10.1056/NEJMoa0706245
61. Cheng J, Zhang W, Zhang X, et al. Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on all-cause mortality, cardiovascular deaths, and cardiovascular events in patients with diabetes mellitus: a meta-analysis. JAMA Intern Med. 2014;174(5):773-785. doi: 10.1001/jamainternmed.2014.348
62. Johnson JA, Simpson SH, Toth EL, et al. Reduced cardiovascular morbidity associated with metformin use in subjects with type 2 diabetes. Diabetic Med. 2005;22(4):497-502. doi: 10.1111/j.1464-5491.2005.01448.x
63. McEwen LN, Karter AJ, Waitzfelder BE. Predictor of mortality over 8 years in type 2 diabetes patients translating research into action for diabetes (TRIAD). Diabetes Care. 2012;35(6):1301-1309. doi: 10.2337/dc11-2281
64. Chuah LL, Papamargaritis D, Pillai D, et al. Morbidity and mortality of diabetes with surgery. Nutr Hosp. 2013;28 Suppl 2:47-52. doi: 10.3305/nh.2013.28.sup2.6713
65. Bolsin SNC, Raineri F, Lo SK, et al. Cardiac cjmplications and mortality rates in diabetic patients following non-cardiac surgery in an Australian teaching hospital. Anaesth Intensive Care. 2009;37(4):561-567.
66. Health and Social Care Information Centre Part of the Government Statistical Service. National Diabetes Audit 2011-2012. Report 2: complications and mortality. Findings about the quality of care for people with diabetes in England and Wales. Report for the audit period 2011-2012. 2013; 25 p.
67. Cregg EW, Gu Q, Cheng YJ, et al. Mortality trends in men and women with diabetes, 1971 to 2000. Ann Intern Med. 2007;147(3):149-155. doi: 10.7326/0003-4819-147-3-200708070-00167
68. Gulliford MC, Charlton J. Is relative mortality of type 2 diabetes mellitus decreasing? Am J Epidemiol. 2009;169(4):455-461. doi: 10.1093/aje/kwn342
69. Nakamura Y, Ueshima H, Kadota A, et al. Alcohol intake and 19-year mortality in diabetic men: NIPPON DATA809. Alcohol. 2009;43(8):635-641. doi: 10.1016/j.alcohol.2009.06.005
70. Lapidus L, Bengtsson C, Bergfors E, et al. Alcohol intake among women and its relationship to diabetes incidence and all-cause mortality. The 32-year follow-up of a population study of women in Gothenburg, Sweden. Diabetes Care. 2005;28(9):2230-2235. doi: 10.2337/diacare.28.9.2230
71. Freiberg MS, Cabral HJ, Heeren TC, et al. Alcohol consumption and the prevalence of the metabolic syndrome in the U.S. A cross sectional analysis of data from the Third National Health and Nutrition Examination Survey. Diabetes Care. 2004;27(11):2954-2959. doi: 10.2337/diacare.27.12.2954
72. NHS National Services Scotland. Alcohol attributable mortality and morbidity: alcohol population attributable fraction for Scotland. NHS National Services. Edinburg, Scotland. 2009. P. 1-50.
73. Bidel S, Hu G, Qiao A, et al. Coffee consumption and risk of total and cardiovascular mortality among patients witn type 2 diabetes. Diabetologia. 2006;49(11):2618-2626. doi: 10.1007/s00125-006-0435-9
74. Комаров Ю.М. О значительных и грубых ошибках при использовании показателей здоровья и здравоохранения. Доступ по ссылке: http://www.rmass.ru/publ/info/oshibki. [Komarov YuM. Significant and grave errors in the use of health indicators and health. Available from: http://www.rmass.ru/publ/info/oshibki. (In Russ.)]
75. Рощин Д.О., Сабгайда Т.П., Евдокушина Г.Н. Проблема учета наличия сахарного диабета при диагностике причин смерти. // Социальные аспекты здоровья населения. – 2012. – Т. 27. - №5. Доступ по ссылке: http://vestnik.mednet.ru/content/view/430/30/lang,ru/ [Roshchin DO, Sabgayda TP, Evdokushina GN. The problem of accounting for the presence of diabetes in the diagnosis of causes of death. Social aspects of population health. 2012; 27(5). Available from: http://vestnik.mednet.ru/content/view/430/30/lang,ru/ (In Russ.)]
76. The NHS International Centre. National Diabetes Audit Mortality Analysis 2007-2008. Key findings on mortality rates for people with diabetes in England. Report for the audit period 2007-2008. 2011. 40 p.
77. Fuller JH, Efford J, Goldblatt P, et al. Diabetes mortality: new light on an underestimated public health problem. Diabetologia. 1983;24(5):336-341. doi: 10.1007/BF00251820
78. Panzram G. Mortality and survival in type 2 (non-insulin-dependent) diabetes mellitus (review). Diabetologia. 1987;30(3):123-131. doi: 10.1007/BF00274216
Supplementary files
Review
For citations:
Asfandiyarova N.S. A review of mortality in type 2 diabetes mellitus. Diabetes mellitus. 2015;18(4):12-21. (In Russ.) https://doi.org/10.14341/DM6846
Views:
244593
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
